| INTRODUCTION
The neurodevelopmental impact of early exposure to general anesthesia (GA) in the pediatric population is still poorly understood.
Data from young animal models suggest that exposure to commonly used anesthetic agents for extended durations or for multiple episodes may result in neurodegenerative histologic changes [1] [2] [3] [4] and downstream effects on social-behavioral and cognitive functioning. [5] [6] [7] [8] [9] Cohort studies in human children have shown mixed results. [10] [11] [12] [13] [14] Notably, the Pediatric Anesthesia Neurodevelopment Assessment (PANDA) study found that anesthesia exposure before 36 weeks of age did not result in statistically significant differences in IQ and other neuropsychiatric test scores between exposed and unexposed siblings measured at age 8-15 years. 15 However, 2 large, recently published cohort studies found modest increased risk for neurodevelopmental deficits in young children exposed to GA at age 2-4 years 16 and after age 2 years 17 compared to children exposed earlier in life. Given the ongoing concerns about this age-specific neurologic vulnerability of young children, the US Food and Drug
Administration recently released a warning about the neurodevelopmental effects of early childhood exposure to drugs used for GA and sedation, "especially for procedures that may last longer than To date, the only randomized controlled trial in human children is the General Anesthesia compared to Spinal anesthesia (GAS) trial. Preliminary results showed no measurable difference in neurodevelopmental outcomes after 2 years in young infants undergoing inguinal hernia repair under general vs spinal anesthesia. 19 In the GAS trial, the median sevoflurane exposure duration was 54 minutes (IQR: 41-70). 19 Although data from this trial suggest that short, single GA exposures may be safe, it is unknown what proportion of pediatric general anesthetics involves longer exposure durations. Currently, largescale studies across broad heterogeneous populations that quantify pediatric GA exposure duration or seek to estimate factors associated with longer exposures are lacking.
| MATERIALS AND METHODS
We estimated pediatric GA exposure duration by performing a retrospective cohort analysis of pediatric general anesthetics in the National Offices. For the purposes of this analysis, we combined the 3 categories of community hospital into a single "Community Hospital" category, we combined the 2 categories of surgery centers into a single "Surgery
Center" category, and we also combined "Pain Clinic," "Surgeon Office,"
and "Dental Office" categories into a single "Other" category. The condensing of these categories was done because the level of granularity provided was above that required for this analysis. Participation is voluntary and each participating entity and provider is de-identified. The NACOR employs a multistaged process of case validation to ensure the accuracy of each case in its database. 21 The NACOR database and similar methodologies have been used successfully in the past with other patient subgroups. 22, 23 Pediatric patients aged 0 days up to 18 years undergoing procedures under GA between January 2010 and March 2015 were included. Exclusion criteria included patients classified as ASA physical status VI (including cases imputed in the NACOR as ASA VI) and patients missing data on age, anesthetic type, and case duration.
Sedation and MAC cases were also excluded from the analysis.
Patients receiving multiple anesthetics over the study period were unlinked. As NACOR does not collect induction and emergence times, exposure duration was defined as the interval between recorded anesthesia start and anesthesia stop. When multiple anesthetic types were listed along with GA, the principal anesthetic technique was assumed to be GA. Given concerns about age-specific neuronal vulnerability of infants and young children, [16] [17] [18] additional analyses were performed focused on children aged <4 years. Summary statistics were used to estimate GA exposure duration.
In post hoc analysis, to further analyze whether avoidable GA exposures were occurring, surgical current procedural terminology (CPT) codes were queried for the 3 most common procedures being conducted in children <4 years and <1 year of age. The most frequent surgical CPT codes were crosschecked against ICD-9 codes to ensure validity. To further explore the issue of excess GA exposure in academic settings, GA duration times for the most common procedure in children <4 and <1 years old, "Procedures of the Middle Ear", and specifically tympanostomy tube placements, were compared between cases performed in university hospital settings vs all other settings. To obtain only tympanostomy tube cases and exclude more complex middle ear procedures, cases were further restricted to those lasting <120 minutes for which only 1 ICD-9 diagnostic code existed and in which the reported anesthesia CPT code, which is the anesthesia billing code derived from the ASA Crosswalk, was for tympanostomy tube placement.
Nonparametric descriptive statistics were used where data were nonnormally distributed, but otherwise parametric techniques were employed. Statistical analyses were completed in R (version 3.3.2).
| RESULTS
Out of 2 473 411 pediatric anesthetics in the NACOR database, 1 756 743 (71.1%) had complete data on anesthesia type and
What is already known
• General anesthesia (GA) exposure duration may be an important determinant of cognitive and neurodevelopmental outcomes in children.
What this article adds
• Roughly half of children requiring surgery with GA are exposed to general anesthetics for approximately an hour or more.
• The vast majority of children undergoing GA are exposed for <3 hours, but certain groups such as very young children (<1 year), older children (older than 12 years), or children receiving care at a university hospital setting or with additional morbidities and complexity may be at increased risk for longer exposures.
BARTELS ET AL. (Table 1) on which the remainder of the analysis was conducted. These complete data came from a total of 1555 unique facilities and 256 practices. Cases with incomplete data on anesthesia type or anesthesia duration (see Table S1 ) had similar distributions as complete cases regarding age, sex, and ASA physical status.
The median age of children in the cohort was 6 years. The majority of cases were ASA I (56%) and II (32%) physical status. GA was the principal anesthetic technique in the vast majority of anesthetics (92.7%). The overall median duration of GA exposure was 57 minutes (IQR: 28-86, Table 2 ). GA duration varied by age, with the longest median durations among <1 year old patients and patients 13 years or older ( Figure 2 ). Overall, younger children (aged: 0-4 years) had median duration 52 minutes (IQR: 23-81), whereas children >4 years were exposed for a median of 60 minutes (IQR: 32-88).
The vast majority of general anesthetics (94%) were <3 hours (Figure 3) . The GA exposure duration 10th and 90th percentiles were 21
and 145 minutes in all patients, 22 and 210 minutes in those aged Sicker patients (ASA III, IV, and V) and care at a university hospital setting were associated with longer GA exposure times. University hospital settings cared for a larger percentage of patients with higher ASA physical status designations; however, anesthetic exposure durations for patients from all ASA classes were higher at university hospital settings than in other facility types ( 
| DISCUSSION
In this study, we found that roughly half of children requiring surgery with GA are exposed to general anesthetics for approximately an hour or more. Very young children (<1 year), older children (≥13 years), as well as sicker children or those treated in an academic hospital setting, tended to have longer exposures. The median GA exposure times estimated from this study in infants <1 year of age were comparable to those reported in the GAS trial (median 54 minutes with IQR: 41-70) 19 suggesting that the findings of the GAS trial may be generalizable to many very young infants in current clinical practice. The longer median GA exposure times found in this very young age group are likely associated with the higher proportion of higher ASA physical status- that also might contribute to adverse neurodevelopmental outcomes.
As the rate of perioperative severe critical events has been shown to increase in patients with higher ASA physical status and among neonates and infants, 24 our finding highlights the complex interplay of patient, surgical, and anesthetic factors when considering the effect of anesthetic duration on patient outcomes and invites further inquiry into determining the extent to which anesthetic exposure duration may be associated with additional patient morbidity and mortality.
As a group, children 1-4 years of age had lower median GA exposure times than both children <1 year and older children, which is reassuring given concerns about GA exposure raised in this vulnerable subpopulation. Furthermore, patients exposed for >3 hours comprised approximately only 6% of the overall study cohort. This provides some reassurance that the large majority of children receiving GA may be at low risk for prolonged exposure times. Still, certain groups, especially patients aged <1 or >13 years, or with additional morbidities and complexity, as reflected by high ASA physical status designations, had longer GA exposure times.
Care at an academic center was also associated with longer GA exposure times. In a post hoc univariate analysis, we estimated 11 minutes of additional exposure during tympanostomy tube placement, while a linear regression adjusting for ASA physical status and with an interaction term between university settings and ASA status estimated approximately 3 minutes of additional exposure time. This adjusted estimate is a small absolute amount, around 10%-20% additional anesthesia time, and may reflect the presence of trainees in academic settings, the culture as it pertains to case duration in academic practice, or unmeasured confounding due to case complexity.
While tympanostomy tube placement was chosen because of its relatively high frequency in young children which enabled a meaningful analysis, the absolute increase in GA exposure duration is unlikely to have a meaningful effect on neurobehavioral and developmental outcomes. One may assume that similar proportional increases may exist for other operations or procedures in university hospitals compared to other settings, although extrapolating this time difference may not be accurate. In addition, while we were able to describe the 
Histogram of pediatric general anesthesia frequency by general anesthetic duration. Note, data truncated to case duration <500 min to better illustrate data distribution [Colour figure can be viewed at wileyonlinelibrary.com] most commonly performed procedures in young children, it is difficult to determine the extent to which these exposures were avoidable. Given the concern for hearing loss or recurrent ear infections, many parents will accept the risk of additional anesthesia time for tympanostomy tube placement. Overall, it is difficult to draw conclusions on the avoidability of these anesthetics.
There are several limitations inherent in this study. First, while GA duration may be an important determinant in the dose-response relationship between exposure and neurodevelopmental outcomes, the contributors of exposure are much more complex, including medication type, dose, timing, and duration. As these data were not included in the NACOR, this analysis cannot comment on other components of exposure. We also used duration of anesthetic care to estimate anesthetic exposure; however, billed anesthetic care time is reasonably representative of time between induction and postoperative care unit admission. Because the NACOR classified the primary anesthetic type as GA if multiple anesthetic types were listed along with GA, this may have resulted in overestimation of GA prevalence and duration. We did not include sedation and MAC cases in this analysis, although the animal data suggest exposure to many of these agents also is associated with the same risks as GA. This may result in a conservative estimate of the number of patients exposed. Also, while the practice of regional techniques in children has been documented as remarkably safe, 25 we were not able to examine whether performance of a regional block under GA, as is commonplace in pediatric anesthesia practice, substantially lengthened exposure durations because these data are not captured adequately in NACOR. However, the time required to perform a regional or neuraxial block under GA should be collected and examined in the future as this practice may warrant additional scrutiny, understanding that the use of a regional block administered as an adjunct to GA may also serve to decrease depth of anesthesia and therefore total dose of systemic agents. | 525
Because participation in NACOR is voluntary, it is unknown whether the sample included is representative of nationwide practice patterns, although the size and diversity of the sample was large. The NACOR does not use a unique identifier, so the proportion of children receiving repeat anesthetic exposures, a putative risk factor in some retrospective cohort analyses, could not be determined. Lastly, approximately 6% and 30% of cases in the sample were missing data on anesthesia duration and type, respectively. However, when compared, incomplete cases had similar distributions as complete cases regarding major covariates, so that this was unlikely a source of major bias.
| CONCLUSION
In this cohort of over 1.5 million children, the duration of general anesthetic exposure is under 1 hour for most pediatric patients, and patients aged 1-12 years typically have the shortest exposure durations. This large cross-sectional sample suggests that more than 90%
of children who receive GA fall outside the parameters stipulated in the FDA warning about anesthetic exposure and neurotoxicity. However, <1 year olds, ≥13 year olds, patients with high ASA physical status designations, and patients receiving care in academic settings were at increased risk for prolonged GA exposure. These risk factors for prolonged exposure should be considered when elective operations are indicated for children who fall into the FDA-defined vulnerable category, and employing mitigating strategies, including increased use of adjunctive agents and techniques that have not been associated with neurotoxicity such as ultrashort-acting opioids, alpha agonists, and regional blockade, or postponement of nonurgent procedures, should be entertained when clinically appropriate. These findings may guide future studies of neurodevelopmental outcomes in children undergoing anesthesia. Further controlled trials are needed to address neurotoxicity risks in infants and young children at highest risk due to prolonged exposure.
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